Cite
HARVARD Citation
Schuler, M. et al. (2016). Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients. BMC cancer. 16 (1), pp. 1-9. [Online].